Neil Cohen - Dec 6, 2021 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role: Director
Signature: /s/ Neil Cohen
Stock symbol: CMMB
Transactions as of: Dec 6, 2021
Transactions value $: $14,860
Form type: 4
Date filed: 12/8/2021, 06:29 AM
Next filing: Mar 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMMB	American Depositary Shares	Purchase	$14.9K	+2K	+83.02%	$7.43^*	4.41K	Dec 6, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CMMB	Option to Purchase American Depositary Shares						11.9K	Dec 6, 2021	American Depositary Shares	11.9K	$27.26	Direct	F1, F3, F4
holding	CMMB	Option to Purchase American Depositary Shares						688	Dec 6, 2021	American Depositary Shares	688	$13.17	Direct	F1, F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2	The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA.
F3	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4	These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
F5	These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service.